1. Submission and Peer Review Process
2. Article Types
3. After Acceptance

For help with submissions, please contact:

Food Safety and Health Editorial Office
Dr. Hui Wang
Email: [email protected] 

Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.

Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.

 

You can now opt to seamlessly preprint your manuscript at submission, through Wiley's Under Review service, powered by Authorea. Make your work citable and discoverable, before it is accepted or published.

 

Food Safety and Health now offers Free Format submission for a simplified and streamlined submission process.

Before you submit, you will need:

• Your manuscript: this should be an editable file including text, figures, and tables, or separate files—whichever you prefer. All required sections should be contained in your manuscript, including abstract, introduction, methods, results, and conclusions. Figures and tables should have legends. Figures should be uploaded in the highest resolution possible. If the figures are not of sufficiently high quality your manuscript may be delayed. References may be submitted in any style or format, as long as it is consistent throughout the manuscript. Supporting information should be submitted in separate files. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers, and the editorial office will send it back to you for revision. Your manuscript may also be sent back to you for revision if the quality of English language is poor.
• An ORCID ID, freely available at https://orcid.org. (Why is this important? Your article, if accepted and published, will be attached to your ORCID profile. Institutions and funders are increasingly requiring authors to have ORCID IDs.)
• The title page of the manuscript, including:
  • Your co-author details, including affiliation and email address. (Why is this important? We need to keep all co-authors informed of the outcome of the peer review process.)
  • Statements relating to our ethics and integrity policies, which may include any of the following (Why are these important? We need to uphold rigorous ethical standards for the research we consider for publication):
    • data availability statement
    • funding statement
    • conflict of interest disclosure
    • ethics approval statement
    • patient consent statement
    • permission to reproduce material from other sources
    • clinical trial registration

This journal is a Gold Open Access title. APC will be waived currently for submissions to Food Safety and Health. You can read more about APCs and whether you may be eligible for waivers or discounts, through your institution, funder, or a country waiver. For more information on this journal’s APCs and licensing policy, please visit the journal’s Open Access page. 

Please find the Wiley preprint policy here.

This journal accepts articles previously published on preprint servers.

Food Safety and Health will consider for review articles previously available as preprints. You are requested to update any pre-publication versions with a link to the final published article. You may also post the final published version of the article immediately after publication.

This Journal operates a double-anonymized peer review process. Authors are responsible for anonymizing their manuscript in order to remain anonymous to the reviewers throughout the peer review process (see “Main Text File” above for more details). Since the journal also encourages posting of preprints, however, please note that if authors share their manuscript in preprint form this may compromise their anonymity during peer review.

This journal encourages data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.

Please review Wiley’s Data Citation policy.

 

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication. Please review Wiley’s Data Protection Policy to learn more.

You should list all funding sources in the Funding/Acknowledgments section. You are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature.

All listed authors should have contributed to the manuscript substantially and have agreed to the final submitted version. Review editorial standards and scroll down for a description of authorship criteria.

Authors may now include their personal pronouns in the author bylines of their published articles and on Wiley Online Library. Authors will never be required to include their pronouns; it will always be optional for the author.  Authors can include their pronouns in their manuscript upon submission and can add, edit, or remove their pronouns at any stage upon request. Submitting/corresponding authors should never add, edit, or remove a coauthor’s pronouns without that coauthor’s consent. Where post-publication changes to pronouns are required, these can be made without a correction notice to the paper, following Wiley’s Name Change Policy to protect the author’s privacy. Terms which fall outside of the scope of personal pronouns (e.g. proper or improper nouns), are currently not supported.

This journal requires ORCID for corresponding author. Please refer to Wiley’s resources on ORCID.

If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is your responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ.

The corresponding author is responsible for obtaining written permission to reproduce the material "in print and other media" from the publisher of the original source, and for supplying Wiley with that permission upon submission.

The title page should contain: 

1. A brief informative title containing the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);
2. The full names of the authors;
3. The author's institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
4. Acknowledgments.

For journals operating a double-anonymized peer review process, please ensure that all identifying information such as author names and affiliations, acknowledgements or explicit mentions of author institution in the text are on a separate page.

The main text file should be in Word or PDF format.

Your main document file should include:

• A short informative title containing the major key words. The title should not contain abbreviations;
• The full names of the authors with institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
• Acknowledgments;
• Abstract unstructured;
• Up to ten keywords;
• Main body: formatted as introduction, materials & methods, results, discussion, conclusion;
• References;
• Tables (each table complete with title and footnotes);
• Figure legends: Legends should be supplied as a complete list in the text. Figures should be uploaded as separate files (see below).

This journal uses the American Psychological Association reference style. Review your reference style guidelines prior to submission.

Figures, supporting information, and appendices should be supplied as separate files. You should review the basic figure requirements for manuscripts for peer review, as well as the more detailed post-acceptance figure requirements. View Wiley’s FAQs on supporting information.

 

This journal operates under a double-anonymized peer review model. Except where otherwise stated, manuscripts are peer reviewed by at least two anonymous reviewers and an Associate or Assistant Editor. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.

In-house submissions, i.e. papers authored by Editors or Editorial Board members of the title, will be sent to Editors unaffiliated with the author or institution and monitored carefully to ensure there is no peer review bias.

 

Authors may appeal an editorial decision if they feel that the decision to reject was based on either a significant misunderstanding of a core aspect of the manuscript, a failure to understand how the manuscript advances the literature or concerns regarding the manuscript-handling process. Differences in opinion regarding the novelty or significance of the reported findings are not considered as grounds for appeal. To raise an appeal, please contact the journal by email, quoting your manuscript ID number and explaining your rationale for the appeal. The editor’s decision following an appeal consideration is final.

To raise a complaint regarding editorial staff, policy or process please contact the journal in the first instance. If you believe further support outside the journal’s management is necessary, please refer to Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics.

 

Wiley believes that no valuable research should go unshared. This journal participates in Wiley’s Refer & Transfer program. If your manuscript is not accepted, you may receive a recommendation to transfer your manuscript to another suitable Wiley journal, either through a referral from the journal’s editor or through our Transfer Desk Assistant.

 

The journal requires that you include in the manuscript details IRB approvals, ethical treatment of human and animal research participants, and gathering of informed consent, as appropriate. You will be expected to declare all conflicts of interest, or none, on submission. Please review Wiley’s policies surrounding human studies, animal studies, clinical trial registration, biosecurity, and research reporting guidelines.

This journal follows the core practices of the Committee on Publication Ethics (COPE) and handles cases of research and publication misconduct accordingly (https://publicationethics.org/core-practices).

This journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley’s Top 10 Publishing Ethics Tips for Authors and Wiley’s Publication Ethics Guidelines.

Generative Artificial Intelligence tools (GenAI)—such as ChatGPT and others based on large language models (LLMs)—can increase productivity and foster innovation if used appropriately in a safe, ethical and secure manner. STM has general guidance for all stakeholders in scholarly publishing which addresses the role of generative AI technologies. If an author has used a GenAI tool to develop any portion of a manuscript, its use must be described, transparently and in detail, in the Methods section (or via a disclosure or within the Acknowledgements section, as applicable). The author is fully responsible for the accuracy of any information provided by the tool and for correctly referencing any supporting work on which that information depends. GenAI tools must not be used to create, alter or manipulate original research data and results. Tools that are used to improve spelling, grammar, and general editing are not included in the scope of these guidelines. The final decision about whether use of a GenAI tool is appropriate or permissible in the circumstances of a submitted manuscript or a published article lies with the journal’s editor or other party responsible for the publication’s editorial policy.

GenAI tools cannot be considered capable of initiating an original piece of research without direction by humans. Tools cannot be accountable for a published work or for research design, which is a generally held requirement of authorship (as discussed in the Authorship section in these guidelines), nor does it have legal standing or the ability to hold or assign copyright. Therefore—in accordance with COPE’s position statement on Authorship and AI tools—these tools cannot fulfil the role of, nor be listed as, an author of an article.

GenAI tools should be used only on a limited basis in connection with peer review. A GenAI tool can be used by an editor or peer reviewer to improve the quality of the written feedback in a peer review report. This use must be transparently declared upon submission of the peer review report to the manuscript’s handling editor. Independent of this limited use case, editors or peer reviewers should not upload manuscripts (or any parts of manuscripts including figures and tables) into GenAI tools or services. GenAI tools may use input data for training or other purposes, which could violate the confidentiality of the peer review process, privacy of authors and reviewers, and the copyright of the manuscript under review. Moreover, the peer review process is a human endeavor and responsibility and accountability for submitting a peer review report, in line with a journal’s editorial polices and peer review model, sits with those individuals who have accepted an invitation from a journal to undertake the peer review of a submitted manuscript. This process should not be delegated to a GenAI tool.

Sensory Evaluation Involving Humans
By definition, sensory evaluation studies of food products on panelists and other sensory-consumer studies involving humans now require an ethical statement. If ethical approval is not mandated by national laws, authors should provide an exemption from the ethics committee with a relevant reference number. In cases where a formal ethics committee or documentation process is unavailable, authors are required to explain this and confirm that appropriate protocols were applied to protect participants' rights and privacy. This includes ensuring no coercion to participate, full disclosure of study requirements and risks, obtaining written or verbal consent from participants, ensuring non-disclosure of participant data without their knowledge, and allowing participants to withdraw from the study at any time. Furthermore, the publication of photographs revealing a participant's identity must be accompanied by a release signed by the participant.

For all articles, the journal mandates the CRediT (Contribution Roles Taxonomy)—more information is available on our Author Services site.

 

Article Type	Description	Word Limit	Abstract / Structure	Other Requirements
Meeting Abstract	Key points of some research ideas, experiments and results for academic exchange	1000 limit	Yes, unstructured
Commentary	Expert opinion from one or more people (who may agree or disagree) on a published work, current understanding/status of an area, or how practice should be undertaken. Generally with references.	broad interest 1500 limit / invited 1000 limit	No
Editorial	To convey an opinion, or overview of an issue, by the Editor or someone invited by the editor		No
News	Frontiers, hotspots and important events of academic research	1000 limit	No
Opinion	Personal opinion on a topic, often with a novel/imaginative approach to a provocative question, with an engaging though rigorous investigation that enhances the understanding of the subject, including new developments, and moderate referencing	1500 ~ 5000 words	Yes, unstructured
Profile	Profile of editors, experts or authors	1000 limit	No
Research Article	Reports of original research, with methods, findings and conclusions.	3000 ~ 6000 words	Yes, unstructured	Data and Code Availability IRB Statement
Review Article	Overview of developments in fields or the current lines of thought. Synthesizes multiple sources of information and has long list of references. Emphasis is more factual and less on opinion.	3000 ~ 12000 words,	Yes, unstructured
Letter	Brief observations and research reports in a concise format.	1500 ~ 3000 words	Yes, unstructured

After your paper is accepted, your files will be assessed by the editorial office to ensure they are ready for production. You may be contacted if any updates or final files are required. Otherwise, your paper will be sent to the production team.

When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. You will be asked to sign a publication license at this point as well as pay for any applicable APCs.

Food Safety and Health is an Open Access journal: authors of accepted papers pay an Article Publication Charge and their papers are published under a Creative Commons license. This journal uses the CC-BY Creative Commons License. Note that certain funders mandate a particular type of CC license be used. For more information on this journal’s APCs and licensing policy, please visit the journal’s Open Access page.

Please review Wiley’s guidelines on sharing your research here. The submitted version of the manuscript, the accepted version, and the published version (Version of Record) can all be deposited on an institutional or other repository of the author's choice without embargo.
 

Upon publication, articles are available as full text HTML or PDF in Early View prior to inclusion in an issue and can be cited as references using their Digital Object Identifier (DOI) number.

Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs online/with their proofs included as a pdf. Authors should also make sure that any renumbered tables, figures, or references match text citations and that figure legends correspond with text citations and actual figures. Proofs must be returned within 48 hours of receipt of the email.

Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves.

 

In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request.

In accordance with Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics’ guidance, Food Safety and Health will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form and contact either the journal’s editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form. Correcting the authorship is different from changing an author’s name; the relevant policy for that can be found in Wiley’s Best Practice Guidelines under “Author name changes after publication.

This journal is part of Wiley’s Open Research Badges program.

The journal’s abstract will be presented in graphical form with a brief abstract.

The table of contents entry must include the article title, the authors' names (with the corresponding author indicated by an asterisk), no more than 80 words or 3 sentences of text summarizing the key findings presented in the paper and a figure that best represents the scope of the paper.

Table of contents entries should be submitted to as ‘Supplementary material for review’ during the initial manuscript submission process.

The image supplied should fit within the dimensions of 50mm x 60mm and be fully legible at this size. 

Color figures. Color figures may be published online free of charge;

The journal supports the Resource Identification Initiative, which aims to promote research resource identification, discovery, and reuse. This initiative, led by the Neuroscience Information Framework and the Oregon Health & Science University Library, provides unique identifiers for antibodies, model organisms, cell lines, and tools including software and databases. These IDs, called Research Resource Identifiers (RRIDs), are machine-readable and can be used to search for all papers where a particular resource was used and to increase access to critical data to help researchers identify suitable reagents and tools.

You will be asked to use RRIDs to cite the resources used in your research where applicable in the text, similar to a regular citation or Genbank Accession number. For antibodies, you should include in the citation the vendor, catalogue number, and RRID both in the text and upon first mention in the Methods section. For software tools and databases, please provide the name of the resource followed by the resource website, if available, and the RRID. For model organisms, the RRID alone is sufficient.

Additionally, you must include the RRIDs in the list of keywords associated with the manuscript.

1. Use the Resource Identification Portal, created by the Resource Identification Initiative Working Group.
2. Search for the research resource (please see the section titled “Search Features and Tips” for more information).
3. Click on the “Cite This” button to obtain the citation and insert the citation into the manuscript text.

If there is a resource that is not found within the Resource Identification Portal, you are asked to register the resource with the appropriate resource authority. Information on how to do this is provided in the “Resource Citation Guidelines” section of the Portal.

If any difficulties in obtaining identifiers arise, please contact [email protected] for assistance.

Antibodies: "Wnt3 was localized using a rabbit polyclonal antibody C64F2 against Wnt3 (Cell Signaling Technology, Cat# 2721S, RRID: AB_2215411)"

Model Organisms: "Experiments were conducted in c. elegans strain SP304 (RRID:CGC_SP304)"

Cell lines: "Experiments were conducted in PC12 CLS cells (CLS Cat# 500311/p701_PC-12, RRID:CVCL_0481)"

Tools, Software, and Databases: "Image analysis was conducted with CellProfiler Image Analysis Software, V2.0 (http://www.cellprofiler.org, RRID:nif-0000-00280)"

Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used.

Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see varnomen.hgvs.org, where examples of acceptable nomenclature are provided.

Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL, or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL, and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’. Addresses are as follows:

• DNA Data Bank of Japan (DDBJ): ddbj.nig.ac.jp
• EMBL Nucleotide Archive: ac.uk/ena
• GenBank: ncbi.nlm.nih.gov/genbank

Proteins sequence data should be submitted to either of the following repositories:

• Protein Information Resource (PIR): georgetown.edu
• SWISS-PROT: ch/sprot/sprot-top

For papers describing structural data, atomic coordinates and the associated experimental data should be deposited in the appropriate databank (see below). Please note that the data in databanks must be released, at the latest, upon publication of the article. We trust in the cooperation of our authors to ensure that atomic coordinates and experimental data are released on time.

• Organic and organometallic compounds: Crystallographic data should not be sent as Supporting Information, but should be deposited with the Cambridge Crystallographic Data Centre (CCDC) at cam.ac.uk/services/structure%5Fdeposit.
• Inorganic compounds: Fachinformationszentrum Karlsruhe (FIZ; fiz-karlsruhe.de).
• Proteins and nucleic acids: Protein Data Bank (https://www.rcsb.org/).
• NMR spectroscopy data: BioMagResBank (wisc.edu).

 

• Concepts illustrated in graphical material must clearly fit with the research discussed in the accompanying text.
• Images featuring depictions or representations of people must not contain any form of objectification, sexualization, stereotyping, or discrimination. We also ask authors to consider community diversity in images containing multiple depictions or representations of people.
• Inappropriate use, representation, or depiction of religious figures or imagery, and iconography should be avoided.
• Use of elements of mythology, legends, and folklore might be acceptable and will be decided on a case-by-case basis. However, these images must comply with the guidelines on human participants when they are present.
• Generally, authors should consider any sensitivities when using images of objects that might have cultural significance or may be inappropriate in the context (for example, religious texts, historical events, and depictions of people).
• Legal requirements:
  • All necessary copyright permission for the reproduction of the graphical elements used in visuals must be obtained prior to publication.
  • Clearance must be obtained from identifiable people before using their image on the cover or the like and such clearance must specify that it will be used on the cover. Use within text does not require such clearance unless it discloses sensitive personal information such as medical information. In all situations involving disclosure of such personal info, specific permission must be obtained. And images of individuals should not be used in a false manner.

 

This journal has the option for authors to embed rich media (i.e. video and audio) within their final article. These files should be submitted with the manuscript files online, using either the “Embedded Video” or “Embedded Audio” file designation. If the video/audio includes dialogue, a transcript should be included as a separate file. The combined manuscript files, including video, audio, tables, figures, and text must not exceed 350 MB. For full guidance on accepted file types and resolution please see here.

Ensure each file is numbered (e.g. Video 1, Video 2, etc.). Legends for the rich media files should be placed at the end of the article.

The content of the video should not display overt product advertising. Educational presentations are encouraged.

Any narration should be in English, if possible. A typed transcript of any speech within the video/audio should be provided. An English translation of any non-English speech should be provided in the transcript.

All embedded rich media will be subject to peer review. Editors reserve the right to request edits to rich media files as a condition of acceptance. Contributors are asked to be succinct, and the Editors reserve the right to require shorter video/audio duration. The video/audio should be high quality (both in content and visibility/audibility). The video/audio should make a specific point; particularly, it should demonstrate the features described in the text of the manuscript.

Participant Consent: It is the responsibility of the corresponding author to seek informed consent from any identifiable participant in the rich media files. Masking a participant’s eyes, or excluded head and shoulders is not sufficient. Please ensure that a consent form (https://authorservices.wiley.com/author-resources/Journal-Authors/licensing/licensing-info-faqs.html) is provided for each participant.

Author Guidelines last updated: June 2024